Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

218.00SEK
22 May 2019
Change (% chg)

7.50kr (+3.56%)
Prev Close
210.50kr
Open
211.00kr
Day's High
218.00kr
Day's Low
206.00kr
Volume
27,674
Avg. Vol
14,202
52-wk High
219.00kr
52-wk Low
115.00kr

Latest Key Developments (Source: Significant Developments)

Infant Bacterial Therapeutics Q1 Operating Loss Narrows To SEK 0.9 Mln
Monday, 6 May 2019 

May 6 (Reuters) - Infant Bacterial Therapeutics AB ::REG-INFANT BACTERIAL THERAPEUTICS AB (PUBL) INTERIM MANAGEMENT STATEMENT, JANUARY 1 – MARCH 31, 2019.JAN-MARCH OPERATING LOSS -929 KSEK (-9 144).  Full Article

Infant Bacterial Therapeutics Q4 Operating Loss Widens To SEK 23.8 Million
Friday, 8 Feb 2019 

Feb 8 (Reuters) - Infant Bacterial Therapeutics AB ::Q4 OPERATING LOSS SEK 23.8 MILLION VERSUS LOSS SEK 9.1 MILLION YEAR AGO.  Full Article

Infant Bacterial Therapeutics Q3 Operating Loss Widens To SEK 7.7 Million
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Infant Bacterial Therapeutics AB ::JULY-SEPT OPERATING LOSS SEK 7.7 MILLION VERSUS LOSS SEK 4.6 MILLION YEAR AGO.  Full Article

Infant Bacterial Therapeutics Q4 Operating Loss Narrows To Sek 9.1 Mln
Wednesday, 28 Feb 2018 

Feb 28 (Reuters) - Infant Bacterial Therapeutics Ab ::Q4 NET SALES SEK 0 VERSUS SEK 113,000 YEAR AGO‍​.Q4 OPERATING LOSS SEK 9.1 MILLION VERSUS LOSS SEK 14.1 MILLION YEAR AGO.BOARD PROPOSES NO DIVIDEND FOR FY 2017.  Full Article

Infant Bacterial Therapeutics announces capital raise
Friday, 24 Nov 2017 

Nov 24 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB :REG-INFANT BACTERIAL THERAPEUTICS ANNOUNCES CAPITAL RAISE OF APPROXIMATELY SEK 545 MILLION IN TOTAL.‍DIRECTED ISSUE OF APPROXIMATELY SEK 105 MILLION HAS BEEN SUBSCRIBED FOR​.‍SUBSCRIPTION PRICE IN DIRECTED ISSUE WAS SEK 95 PER SHARE​.  Full Article

Infant Bacterial Therapeutics Q3 operating loss narrows to SEK ‍​4.6 mln
Thursday, 23 Nov 2017 

Nov 23 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB :Q3 OPERATING LOSS SEK ‍​4.6 MILLION VERSUS LOSS SEK 7.9 MILLION YEAR AGO.  Full Article

EMA adopts positive opinion on paediatric investigation plan for IBT's lead product
Thursday, 28 Sep 2017 

Sept 28 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB (IBT) :REG-EUROPEAN MEDICINES AGENCY (EMA) ADOPTS A POSITIVE OPINION ON THE PAEDIATRIC INVESTIGATION PLAN FOR IBT'S LEAD PRODUCT.‍WE ARE NOW PREPARING FOR PHASE 3 STUDY - CEO​.  Full Article

Infant Bacterial Therapeutics Q2 oper loss at SEK 13.8 mln
Monday, 28 Aug 2017 

Aug 28 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB :Q2 NET SALES 121 KSEK (-).Q2 OPERATING LOSS -13 826 KSEK (-10 975).  Full Article

BRIEF-Infant Bacterial Therapeutics AB Announces First Distribution Agreement

* SIGNED FIRST DISTRIBUTION AGREEMENT FOR IBP-9414 WITH MEGAPHARM LTD. FOR THE ISRAELI MARKET AND THE PALESTINIAN AUTHORITY'S TERRITORIES